In the latest quarter, 6 analysts provided ratings for Dentsply Sirona (NASDAQ:XRAY), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ...
Oct 24 (Reuters) - (This Oct. 24 story has been corrected to say that Dentsply Sirona suspended sales of its 'Byte' teeth aligners, not all aligners in the headline) Dentsply Sirona (XRAY.O ...
Baird lowered the firm’s price target on Dentsply Sirona (XRAY) to $24 from $31. The firm said with implant and equipment pressures continuing, shares were likely going to be down today.